Home/Filings/4/0001415889-24-009989
4//SEC Filing

St Leger Tina Amber 4

Accession 0001415889-24-009989

CIK 0001671927other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:15 PM ET

Size

9.5 KB

Accession

0001415889-24-009989

Insider Transaction Report

Form 4
Period: 2024-04-01
St Leger Tina Amber
CHIEF HR OFFICER
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2024-04-01$29.87/sh+4,375$130,6814,375 total
  • Sale

    Ordinary Shares

    2024-04-01$64.06/sh4,375$280,2630 total
  • Exercise/Conversion

    Employee Share Option (Right to Buy)

    2024-04-014,37535,000 total
    Exercise: $29.87Exp: 2032-03-31Ordinary Shares (4,375 underlying)
Footnotes (3)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.73 to $64.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]25% of the shares subject to the option award vested on April 1, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Issuer

Immunocore Holdings plc

CIK 0001671927

Entity typeother

Related Parties

1
  • filerCIK 0001969525

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:15 PM ET
Size
9.5 KB